Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥2,005,468 | CN¥2,195,337 | CN¥1,725,715 | CN¥1,733,784 |
| % Growth | -8.6% | 27.2% | -0.5% | – |
| Cost of Goods Sold | CN¥1,709,998 | CN¥2,015,535 | CN¥1,541,011 | CN¥1,925,630 |
| Gross Profit | CN¥295,470 | CN¥179,802 | CN¥184,705 | -CN¥191,845 |
| % Margin | 14.7% | 8.2% | 10.7% | -11.1% |
| R&D Expenses | CN¥4,062 | CN¥3,773 | CN¥4,536 | CN¥8,107 |
| G&A Expenses | CN¥0 | CN¥83,380 | CN¥98,314 | CN¥97,649 |
| SG&A Expenses | CN¥129,614 | CN¥107,166 | CN¥116,775 | CN¥122,697 |
| Sales & Mktg Exp. | CN¥0 | CN¥23,786 | CN¥18,462 | CN¥25,048 |
| Other Operating Expenses | CN¥23,928 | CN¥34,224 | CN¥42,509 | -CN¥557 |
| Operating Expenses | CN¥157,603 | CN¥145,163 | CN¥163,821 | CN¥130,247 |
| Operating Income | CN¥137,866 | CN¥34,639 | CN¥20,884 | -CN¥322,092 |
| % Margin | 6.9% | 1.6% | 1.2% | -18.6% |
| Other Income/Exp. Net | -CN¥22,426 | -CN¥302 | -CN¥240 | -CN¥3,093 |
| Pre-Tax Income | CN¥115,440 | CN¥34,337 | CN¥20,644 | -CN¥325,185 |
| Tax Expense | CN¥79,237 | CN¥1,633 | CN¥13,109 | -CN¥58,903 |
| Net Income | CN¥41,337 | CN¥39,254 | CN¥12,517 | -CN¥189,854 |
| % Margin | 2.1% | 1.8% | 0.7% | -11% |
| EPS | 0.005 | 0.005 | 0.002 | -0.024 |
| % Growth | 4% | 212.5% | 106.8% | – |
| EPS Diluted | 0.004 | 0.004 | 0.001 | -0.02 |
| Weighted Avg Shares Out | 7,973,724 | 7,823,321 | 7,823,321 | 8,051,750 |
| Weighted Avg Shares Out Dil | 10,334,254 | 10,431,094 | 10,431,094 | 9,467,532 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥15,747 | CN¥14,952 | CN¥10,753 | CN¥18,214 |
| Interest Expense | CN¥29,376 | CN¥29,460 | CN¥27,558 | CN¥6,543 |
| Depreciation & Amortization | CN¥0 | CN¥238,591 | CN¥243,671 | CN¥243,671 |
| EBITDA | CN¥148,061 | CN¥275,459 | CN¥288,838 | -CN¥106,982 |
| % Margin | 7.4% | 12.5% | 16.7% | -6.2% |